Predictors of Pregnancy after Artificial Insemination in Women with Polycystic Ovary Syndrome
- PMID: 39983029
- PMCID: PMC12225176
- DOI: 10.5935/1518-0557.20240095
Predictors of Pregnancy after Artificial Insemination in Women with Polycystic Ovary Syndrome
Abstract
Objective: Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, being one of the main causes of infertility. Anti-Müllerian hormone (AMH) is an important marker of ovarian reserve and has been proposed as an alternative criterion for the diagnosis of PCOS. This study verifies whether AMH and body mass index (BMI) values are predictors of pregnancy in infertile women with PCOS undergoing artificial insemination (AI), a less invasive and painless technique of assisted reproductive technologies (ART).
Methods: This retrospective observational study involved 220 women with PCOS who underwent AI between 2010 and 2022. Participants were categorized into three groups based on BMI and serum AMH levels. To categorize the three AMH classes, the 25th (4.08ng/mL) and 75th (8.99ng/mL) AMH percentiles were defined as cut-offs, and the words 'low', 'middle', and 'high' were utilized to define the groups.
Results: There was a tendency towards a decrease in reproductive outcomes (number of inseminations with positive human-chorionic gonadotropin, number of live births, and number of term births) with an increase in the BMI value. All of these outcomes were also slightly higher in women with 'middle' AMH levels compared to women with 'low' and 'high' AMH. However, none of these results were statistically significant.
Conclusions: This study suggests BMI may be an important predictive factor for pregnancy and there appears to be a range of biological normality for AMH values, where 'low' and 'high' levels of this hormone could constitute a marker of poor reproductive prognosis, in women with PCOS undergoing AI.
Keywords: anti-Müllerian hormone; artificial insemination; body mass index; intrauterine insemination; polycystic ovary syndrome; reproductive outcomes.
Similar articles
-
In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.Cochrane Database Syst Rev. 2025 Feb 6;2(2):CD006606. doi: 10.1002/14651858.CD006606.pub5. Cochrane Database Syst Rev. 2025. PMID: 39912435
-
Gonadotropins for ovulation induction in women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2025 Apr 7;4(4):CD010290. doi: 10.1002/14651858.CD010290.pub4. Cochrane Database Syst Rev. 2025. PMID: 40193219
-
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD010287. doi: 10.1002/14651858.CD010287.pub4. Cochrane Database Syst Rev. 2022. PMID: 36165742 Free PMC article.
-
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2018 May 24;5(5):CD010287. doi: 10.1002/14651858.CD010287.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2022 Sep 27;9:CD010287. doi: 10.1002/14651858.CD010287.pub4. PMID: 29797697 Free PMC article. Updated.
-
Evaluating serum anti-Müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome in Pakistani women.Int J Gynaecol Obstet. 2025 Jun 25. doi: 10.1002/ijgo.70240. Online ahead of print. Int J Gynaecol Obstet. 2025. PMID: 40560122
Cited by
-
Predictive value of serum sortilin, HMGB1, and galanin-like peptide for gestational diabetes mellitus in women with polycystic ovary syndrome.Front Endocrinol (Lausanne). 2025 May 19;16:1602622. doi: 10.3389/fendo.2025.1602622. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40458174 Free PMC article.
-
Predictive value of AMH in late reproductive age: a retrospective cohort study.Sci Rep. 2025 Jul 1;15(1):21073. doi: 10.1038/s41598-025-07411-w. Sci Rep. 2025. PMID: 40596221 Free PMC article.
-
Polycystic ovary syndrome and excessive body weight impact independently and synergically on fertility treatment outcomes.Reprod Biol Endocrinol. 2025 Jul 7;23(1):97. doi: 10.1186/s12958-025-01434-8. Reprod Biol Endocrinol. 2025. PMID: 40624700 Free PMC article.
-
The impact of pre-pregnancy overweight/obesity on the birth weight of offspring born from women with polycystic ovarian syndrome.BMC Pregnancy Childbirth. 2025 Jul 4;25(1):725. doi: 10.1186/s12884-025-07755-1. BMC Pregnancy Childbirth. 2025. PMID: 40616005 Free PMC article.
References
-
- Alnakash AH, Al-Tae’e NK. Polycystic ovarian syndrome: The correlation between the LH/FSH ratio and disease manifestations. Middle East Fertil Soc J. 2007;12:35–40.
-
- Bayer SR, Alper MM, Penzias AS. The Boston IVF handbook of infertility: a practical guide for practitioners who care for infertile couples. 4th. San Diego: CRC Press, Taylor & Francis Group; 2018.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical